Navigation Links
Biomedical researchers create artificial human bone marrow in a test tube
Date:12/22/2008

ANN ARBOR, Mich.--- Artificial bone marrow that can continuously make red and white blood cells has been created in a University of Michigan lab.

This development could lead to simpler pharmaceutical drug testing, closer study of immune system defects and a continuous supply of blood for transfusions.

The substance grows on a 3-D scaffold that mimics the tissues supporting bone marrow in the body, said Nicholas Kotov, a professor in the U-M departments of Chemical Engineering; Materials Science and Engineering; and Biomedical Engineering.

The marrow is not made to be implanted in the body, like most 3-D biomedical scaffolds. It is designed to function in a test tube.

Kotov, principal investigator, is an author of a paper about the research currently published online in the journal Biomaterials. Joan Nichols, professor from the University of Texas Medical Branch, collaborated on many aspects of the project.

"This is the first successful artificial bone marrow," Kotov said. "It has two of the essential functions of bone marrow. It can replicate blood stem cells and produce B cells. The latter are the key immune cells producing antibodies that are important to fighting many diseases."

Blood stem cells give rise to blood as well as several other types of cells. B cells, a type of white blood cell, battle colds, bacterial infections, and other foreign or abnormal cells including some cancers.

Cancer-fighting chemotherapy drugs can strongly suppress bone marrow function, leaving the body more susceptible to infection. The new artificial marrow could allow researchers to test how a new drug at certain potencies would affect bone marrow function, Kotov said. This could assist in drug development and catch severe side effects before human drug trials.

Bone marrow is a complicated organ to replicate, Kotov said. Vital to the success of this new development is the three-dimensional scaffo
'/>"/>

Contact: Nicole Casal Moore
ncmoore@umich.edu
734-647-1838
University of Michigan
Source:Eurekalert

Page: 1 2

Related biology news :

1. University of Miami biomedical engineer
2. Biomedical research profits from the exploration of the deep sea
3. Biomedical engineers detective work reveals antibiotic mechanism
4. Supercomputer provides massive computational boost to biomedical research at TGen
5. Johnson & Johnson honors 2008 recipients of the Dr. Paul Janssen Award for Biomedical Research
6. NJIT biomedical engineer receives NSF Career Development Award
7. Springer expands publishing partnership with the Biomedical Engineering Society
8. UVa biomedical engineering study shows magnetic field can reduce swelling
9. Phase 2 of Singapores Biomedical Sciences Initiative gains momentum for clinical research
10. USC biomedical team to participate in $6 million low vision project
11. $22 million gift from Alfred Taubman launches new biomedical research institute

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)... Center and the Chinese Academy of Sciences (CAS) ...on Taste and Smell Research. Organized by Monell i...the first international meeting on taste and smell...utive Officer, American Association for the Advanc...e magazine, will open the meeting with a plenary a...
(Date:11/5/2009)...ty have developed synthetic molecules capable of e...-infected cells, as well as to prostate cancer cel...al of the American Chemical Society , could lead t... , The molecules called "antibody-recruiting m...iting molecule targeting prostate cancer" (ARM-P) ...
(Date:11/4/2009)...ant to officially endorse green tea as a cancer pr...its protective effects, including results of a new...a journal of the American Association for Cancer R...cer. , Vassiliki Papadimitrakopoulo, M.D., prof...ad and Neck Medical Oncology at the University of ...
Breaking Biology News(10 mins):Monell Center joins with CAS to host Beijing meeting on taste and smell research 2New synthetic molecules trigger immune response to HIV and prostate cancer 2Does green tea prevent cancer? Evidence continues to brew, but questions remain 2UNC scientists garner new NIH awards for high risk transformative research 10076 1UNC scientists garner new NIH awards for high risk transformative research 10076 2UNC scientists garner new NIH awards for high risk transformative research 10076 3UNC scientists garner new NIH awards for high risk transformative research 10076 4Thomson Reuters Predicts Nobel Laureates 14245 1Thomson Reuters Predicts Nobel Laureates 14245 2Thomson Reuters Predicts Nobel Laureates 14245 3Thomson Reuters Predicts Nobel Laureates 14245 4Thomson Reuters Predicts Nobel Laureates 14245 5Thomson Reuters Predicts Nobel Laureates 14245 6RetireSafe to Senate 3A Stop Proposed Rationing of High Quality Hospital Care Medicare Needs More Physician Hospitals 58219 1RetireSafe to Senate 3A Stop Proposed Rationing of High Quality Hospital Care Medicare Needs More Physician Hospitals 58219 2
.... A hypertension medication called olmesartan med...the arteries that occurs in patients with high blo... Ferrario, M.D., one of the study,s lead investiga... Research Center at Wake Forest University Baptist... the growing evidence for the role of angiotensin ...
...he Smithsonian,s National Zoo have performed the f...s horse ( E. ferus przewalskii ; E. caballus prze...-VAL-skeez. Przewalksi,s horses are a horse specie...xtinct in the wild in 1970. Currently, there are a...oological institutions throughout the world and in...
...nce and technology policymaking capacity of the Wh...ent can better address key issues facing the natio...rity, and the ability of the United States to comp...primary recommendations are that: , The next P...ader to be Assistant for Science and Technology Po...
Other Biology News:Hypertension treatment effective in reversing vascular damage 2First successful reverse vasectomy on endangered species performed at the National Zoo 2First successful reverse vasectomy on endangered species performed at the National Zoo 3White House science office needs upgrade 2White House science office needs upgrade 3
(Date:11/6/2009)...NA, Austria, November 6 EUCODIS Bi...acturing, and marketing enzymes for the,chemical i... research,agreement with Bio Sidus, the leading bi... The agreement gives EUCODIS Bioscience exclusiv... to Bio Sidus, proprietary collection of,psychroph...
(Date:11/6/2009)... The agenda for Arrowhead’s 2010 ...ch is set to take place on February 22-24, 2010 in...ay conference we will highlight key issues in form...hare their experiences. , ...genda for Arrowhead’s 2010 Personalized Med...
(Date:11/5/2009)...O, Nov. 5 Imagenetix, In...t William Spencer, President and CEO of Imagenetix...d annual LD MICRO Conference on Thursday, December...geles. ,, About LD MICRO ,, LD MICRO is a by...inding undervalued companies in the micro-cap spac...
(Date:11/5/2009)...E, Calif., Nov. 5 Cephei...ives will be speaking at the following investor co...a webcast. , , Credit Suisse Healt...rsday, 12 November, 2009 at 10 a.m. Mountain Time,..., London, England, Tuesday, 1 Dece...
Breaking Biology Technology:EUCODIS Bioscience to Explore Novel Enzymatic Activities in Antarctic Bacteria Library From Bio Sidus 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air 2Cepheid to Webcast Upcoming Financial Presentations 2
... PAREXEL International,Corporation (Nasdaq: PRXL ...anization, today announced the successful completi...tional Clinical Research Co., Ltd. ("APEX") in,a s...uisition and other,factors discussed herein, the C...uidance for the first quarter of Fiscal Year 2008 ...
... Sept. 26 InterMune, Inc.,(Nasdaq: ITMN ) today ...025,000 shares of common stock at a price to the p...s of common stock, representing the exercise,by th...nal shares in the,offering. The net proceeds to th...million, after payment of underwriting discounts a...
...., Sept. 26 Corium International,Inc., a privatel...nounced,that it has completed a $25.1 million Seri...res. Quantum Technology Partners, Aphelion Capital... round. In connection with,the financing, StrataGe...Ventures portfolio company focused on needle-free ...
Other Biology Technology:PAREXEL International Updates Financial Guidance in Conjunction with the Acquisition of APEX International Clinical Research Co., Ltd. and Other Factors 2PAREXEL International Updates Financial Guidance in Conjunction with the Acquisition of APEX International Clinical Research Co., Ltd. and Other Factors 3PAREXEL International Updates Financial Guidance in Conjunction with the Acquisition of APEX International Clinical Research Co., Ltd. and Other Factors 4InterMune Announces Closing of Public Offering of Common Stock 2Corium International, Inc., Announces $40 Million Financing led by Essex Woodlands Health Ventures 2Corium International, Inc., Announces $40 Million Financing led by Essex Woodlands Health Ventures 3Corium International, Inc., Announces $40 Million Financing led by Essex Woodlands Health Ventures 4
Human SLPI ELISA Kit from R&D Systems
Rabbit Anti-Human OLFM1 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
GELase 50X Reaction Buffer from EPICENTRE Biotechnologies
Axl, phospho ELISA development Kit, DuoSet IC Economy Pack from R&D Systems
Biology Products: